MAPK6 and melanoma: On the other hand, the inhibitory roles for ERK3 in tumor cell growth and/or migration have also been reported in several other types of cancers, including melanoma [11], non‐melanoma skin cancer [12], hepatocarcinoma [13], and intrahepatic cholangiocarcinoma [14].